☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
exclusive license agreement
Advancing Neurodegenerative Care: Kasper Roet from QurAlis Corporation in a Stimulating Conversation with PharmaShots
September 2, 2024
NovaRock Signs an Exclusive License Agreement with Flame to Co-Develop and Commercialize NBL-015
August 27, 2021
Meiji and Dong-A ST Sign an Exclusive License Agreement with Intas to Commercialize DMB-3115- Proposed Biosimilar to Ustekinumab
July 23, 2021
Ionis Signs an Exclusive WW License Agreement with Bicycle to Develop Targeted Oligonucleotide Therapeutics Using TfR1 Bicycle Tec...
July 14, 2021
AstraZeneca Signs an Exclusive License Agreement with F-star Therapeutics for Novel STING Inhibitors
July 9, 2021
Takeda Signs an Exclusive License Agreement with Ovid for Soticlestat to Treat Dravet Syndrome and Lennox-Gastaut Syndrome
March 4, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.